Key result
Telestroke-guided tPA yields comparable 90-day functional recovery to in-person stroke center evaluation.
Cohort (n=142)
Yes
Answers are grounded in this paper and cite their sources.
BACKGROUND AND PURPOSE: Telestroke networks offer an opportunity to increase tissue-type plasminogen activator use in community hospitals. METHODS: We compared 83 patients treated with intravenous tissue-type plasminogen activator by telestroke to 59 patients treated after in-person evaluation by the same neurologists at a tertiary care stroke center. Onset and door-to-treatment times and functional outcome at 90 days were obtained prospectively. Favorable outcome was defined as modified Rankin Scale score ≤2. RESULTS: Favorable outcome rates were comparable between the groups (42.1% versus 37.5%, P=0.7). There was no significant difference in the rate of symptomatic hemorrhage. CONCLUSIONS: Telestroke is a viable alternative to in-person evaluation when stroke expertise is not readily available.
No takes yet. Share an insight, caveat, or question.
Zaidi et al. (2011) conducted a cohort in Acute ischemic stroke (n=142). Telestroke-guided intravenous tissue-type plasminogen activator vs. In-person evaluation at a tertiary care stroke center was evaluated on Favorable functional outcome at 90 days (modified Rankin Scale score ≤2) (p=0.7). Telestroke-guided intravenous tPA achieved comparable 90-day favorable functional outcomes (mRS ≤2) to in-person evaluation at a stroke center.
Synapse has enriched 10 related papers. Consider them for comparative context: